Skip to main content
TipRanks
Go Ultimate75% OFF

Cartesian Therapeutics (RNAC) Revenue

1,213 Followers

Cartesian Therapeutics Revenue

Revenue (ttm)
1.02M
Revenue Growth
―
P/S Ratio
75.14
Revenue/Employee
$37,293
Employees
75
Market Cap
$210.17M

Revenue Chart

Cartesian Therapeutics Revenue - Annual

025M50M75M100M125M207.00K903.00K6.68M16.60M85.08M110.78M26.00M38.91M2.80M201720182019202020212022202320242025
Revenue History
Download to Excel
RNAC revenue history
Fiscal End DateRevenueChangeGrowth
Dec 31, 20252.80M-36.12M-92.81%
Dec 31, 202438.91M12.91M49.64%
Dec 31, 202326.00M-84.77M-76.53%
Dec 31, 2022110.78M25.70M30.21%
Dec 31, 202185.08M68.48M412.60%
Dec 31, 202016.60M9.92M148.57%
Dec 31, 20196.68M5.77M639.42%
Dec 31, 2018903.00K696.00K336.23%
Dec 31, 2017207.00K――
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Related stocks
CompanyRevenue
RNAC1.02M
FATE4.75M
CLLS56.59M
CABA0.00
NKTX0.00
IPSC0.00